BioGenerator Ventures
@BioGeneratorSTL
BioGenerator Ventures creates, builds, and invests in companies that are solving important problems in human health and agriculture.
คุณอาจชื่นชอบ
BioGenerator is proud to be the lead investor of this #STL company using technology developed at @WUSTL.
.@sentiarco lands $2.2M federal grant to advance augmented reality cardiac hologram research: biogenerator.org/wp-content/upl… #stl #AR
By helping startups secure financing and develop plans to scale up, BioGenerator Ventures gives new companies a solid foundation -- which supports tech opportunities in a soft job market, too. Listen to this story from @stlpublicradio to learn more: stlpr.org/economy-busine…
stlpr.org
Decline in tech job listings puts a focus on local startups, but challenges abound
To keep St. Louis’ existing tech talent, some regional leaders are pushing for more support for startups. But it’s not a quick or easy fix.
May 14-16, BioGenerator will co-host a 5-part, in-depth workshop on writing and submitting an SBIR/STTR funding proposal to the @NIH (National Institutes of Health). Read more and register today: bit.ly/4dxCYug
BioGenerator is seeking a Sr. Managing Director to lead overall investing & startup support strategy and goals for a portfolio for 70+ companies in the fields of agtech, healthcare, therapeutics, diagnostics, medical devices, & food/nutrition. Learn more: bit.ly/3WvNPiy
Healthcare startup seeking funding? Learn how to craft a competitive SBIR/STTR proposal that meets National Institutes of Health requirements. BioGenerator's NIH SBIR/STTR Proposal Preparation Workshop series starts May 14. Register today: bit.ly/49RiUA0
One week left for one million dollars. The Startup World Cup is taking applications until April 26th to find the top 100 startups to compete for $1M. That means St. Louis startups have one week left to enter for a chance at a dream investment. Game on! techstl.com/worldcup
techstl.com
Startup World Cup - TechSTL
St. Louis competes in the 2024 Startup World Cup $1 million pitch competition with a series of regional events to select the top 10 winning companies.
Could you be BioGenerator Ventures' next Senior Managing Director? The person in this role will oversee our portfolio of more than 70 innovative companies representing billions of dollars in investments. Learn more: biostl.org/contact/job-op…
Congrats to Dr. Martha Schlicher and her #ImpetusAg team, a BioGenerator Ventures portfolio company, for being a winner of The Challenge, an initiative by @UPLLtd & @RadicleGrowth that invests in #agtech startups that focus on natural and biological solutions.
BioGenerator Ventures is delighted to announce a recent equity investment in St. Louis-based INTENT, an ag industry pioneer. The investment is intended to help accelerate INTENT’s industry-changing advancements in agriculture. Read more: bit.ly/3PJsdvj
globalagtechinitiative.com
INTENT Secures Investment From BioGenerator Ventures, Advancing the Ag Tech Ecosystem in St. Louis
Ag industry pioneer and St. Louis-based INTENT has announced an equity investment from BioGenerator Ventures to help accelerate industry-changing
After closing a round of growth financing, BioGenerator Ventures portfolio company Panome Bio will continue its work to gain actionable insights to metabolic pathways involved in cancer, aging, and drug metabolism. ow.ly/Bglj50Oo7sj
Impetus Agriculture, a BioGenerator portfolio company, develops highly effective insect control products to address the $70 billion loss farmers endure every year as a result of crop pests. Learn more about their work: ow.ly/pkmj50NQGJ4
BioGenerator portfolio company @SolisAgrosci is changing how plant science research is conducted. Their Plant Pipeline as a Service assists companies with gene editing, greenhouse operation, plant analysis and more. ow.ly/oCgI50NKBYs
Thank you, Dr. Singh! We are so proud of our BioGenerator portfolio company, SentiAR!
Had an amazing day immersed in Augmented Reality with the SentiAR system. Our first ablation performed using holographic 3-D images. Magical!! The future is here!! @jenniferavari @DrGregMichaud @alanhanley2 @Davilandre @True_EP #EPeeps @JonSilva_StL
Congratulations to Panome Bio for closing a growth financing round! We are proud to have invested in this "discovery services" contract research organization as they use metabolomics and proteomics to discover biomarkers. ow.ly/jmlO50NmRTO
Agtech startup Agragene relocates St. Louis, taking advantage of the region's affordability and startup ecosystem. Read more in @stlouisbiz: ow.ly/ugB050Njnz3
Growing up, Matt Helms developed a passion for plants as he spent time on his family's Belleville farm. Today, he carries on the tradition of agriculture in several ways -- including his work with BioGenerator Ventures. h/t @stlouisbiz ow.ly/S5sp50MX9pj
BioGenSTL portfolio company Impetus Agriculture uses innovation to target a $70B headache for farmers: ow.ly/PuE750MQSmF
BioGenSTL health startup @GeneoscopyCo is ready to commercialize its at-home, preventive screening test for colorectal cancer after strong clinical trial results. ow.ly/PEm550MQRKk
prnewswire.com
Geneoscopy's Noninvasive Colorectal Cancer Screening Test Demonstrates High Sensitivity and...
/PRNewswire/ -- Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced favorable...
BioGenerator company @medibeacon recently advanced a commercial partnership valuing the company at over $400M. This investment enables accelerated development, as well as new global markets open to the product. Learn more about this partnership: ow.ly/BcQr50MKBql
prnewswire.com
MediBeacon Receives $10 Million in Amended Agreements with Huadong Medicine to Accelerate Develop...
/PRNewswire/ -- MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced amendments to its...
Wugen, a BioGenerator portfolio company, recently announced promising advancements in its anti-tumor cell-therapy technology for cancer. Read more: ow.ly/OozZ50MEI2r
wugen.com
Wugen Presents Data Supporting Clinical Development of WU-NK-101 for Relapsed / Refractory AML at...
— Genetic tumor microenvironment (TME) signature identified as highly predictive of duration of response to cytokine-induced memory-like (CIML) NK cell therapy – — WU-NK-101 exhibited enhanced...
STL health startup @GeneoscopyCo is taking steps to commercialize its at-home, preventive screening test for colorectal cancer after a clinical trial yielded strong results. Learn more about the BioGenerator portfolio company's growth in @stlouisbiz: ow.ly/9qX450MxRCA
United States เทรนด์
- 1. Bears 85.5K posts
- 2. Jake Moody 12.5K posts
- 3. Snell 22.1K posts
- 4. Falcons 49.5K posts
- 5. Bills 137K posts
- 6. Josh Allen 25.3K posts
- 7. Caleb 46.4K posts
- 8. #BearDown 2,181 posts
- 9. Jayden 21.6K posts
- 10. Swift 287K posts
- 11. #Dodgers 14.5K posts
- 12. Ben Johnson 3,985 posts
- 13. phil 159K posts
- 14. Turang 4,097 posts
- 15. Bijan 31.2K posts
- 16. Roki 5,894 posts
- 17. #RaiseHail 8,301 posts
- 18. Troy Aikman 5,788 posts
- 19. #NLCS 13.9K posts
- 20. Brewers 46.8K posts
คุณอาจชื่นชอบ
Something went wrong.
Something went wrong.